월스트리트 주요 인물들, 엔비디아 주가를 $330로 보는 반면 매수자들은 그냥 나갔다
작성자 Maksym Misichenko · Yahoo Finance ·
작성자 Maksym Misichenko · Yahoo Finance ·
AI 에이전트가 이 뉴스에 대해 생각하는 것
Despite unanimous buy ratings and high price targets, NVIDIA's recent technical indicators suggest weakness, with money flows turning negative and retail volume fading. The panel expresses concern about potential disappointments in Q2 bookings or AI demand, which could lead to multiple contractions and a retest of lower levels.
리스크: Disappointing Q2 bookings data or a slowdown in AI capex growth could compress multiples and push the price toward $200, despite current price targets.
기회: No tangible opportunity was explicitly stated by the panel.
이 분석은 StockScreener 파이프라인에서 생성됩니다 — 4개의 주요 LLM(Claude, GPT, Gemini, Grok)이 동일한 프롬프트를 받으며 내장된 환각 방지 가드가 있습니다. 방법론 읽기 →
엔비디아 주가가 7일 만에 여러 월스트리트 기관으로부터 신규 매수 평가를 받았습니다. 웨이버러스가 가장 높은 목표가 $330을 제시했으며, 제퍼리스와 미즈호는 $300, 모건 스탠리는 $288을 제시했습니다.
하지만 주가는 $236의 고점에서 조정을 시작했습니다. 기관 자금은 5월 27일에 매도세로 전환되었고, 소매 거래량은 5월 15일에 붉은색으로 전환되었습니다. 월스트리트가 원하는 매수자들이 이미 떠난 것으로 보입니다.
현재 엔비디아 주가에 대한 주장이 매우 높은 관심을 받고 있습니다.
웨이버러스 애널리스트 다니엘 아이브스는 5월 21일 목표가를 $330으로 상향 조정했으며, 이는 현재 $214.86 종가 대비 53.59% 상승을 의미합니다. 모건 스탠리의 조셉 무어도 같은 날 $288 매수를 재확인했습니다.
제퍼리스는 5월 22일 $300을, 미즈호는 5월 25일 $300을, 트루이스트 파이낸셜은 $307을 제시했습니다. 심지어 보수적인 기관들도 긍정적입니다. DBS는 $250을 유지하고 있으며, UBS는 목표가를 $275에서 $280으로 상향 조정했습니다.
이번 주 추적된 10개 기관 모두 엔비디아 주가를 매수로 평가했습니다. 그러나 차트는 다른 이야기를 하고 있습니다.
엔비디아 주가는 3월 말 $164.27에서 $236.84까지 44.18% 상승한 후 5월 19일 고점을 기록했습니다. 이후 주가는 상승 추세를 보이는 울타리 모양의 약보패턴(bullish pole-and-flag)과 유사한 좁은 하락 채널 내에서 수렴하고 있습니다.
더 많은 통찰력을 원하신다면 여기에서 편집자 하시 노타리야의 데일리 뉴스레터를 구독하세요.
그러나 자금 흐름 프로파일은 변화했습니다. 차이킨 머니 플로우 지표에 따르면 기관 매수 압력은 5월 27일 이하로 하락했습니다. 이 지표가 마지막으로 제로를 돌파한 것은 3월 중순으로, 그 직후 엔비디아 주가가 13.06% 하락했습니다.
소매 거래량은 5월 15일에 붉은색으로 전환되었으며, 수렴 기간 동안 매도량은 감소하지 않았습니다. 이 두 흐름 신호는 현재 월스트리트 목표와는 반대 방향으로 움직이고 있습니다.
매수 평가와 하락 차트 사이의 판단은 변동성에 달려 있습니다. 엔비디아의 30일 연간 변동성은 현재 33.1%에 달합니다.
이는 비트코인 22.9%, 나스닥-100 14.1%, S&P 500 8.6%를 모두 상회합니다. 또한 테슬라 32.2%와 알파벳 33.7%와도 비슷한 수준입니다.
이런 수준의 변동성을 보이는 주가는 감정이 급변할 때 기술적 설정을 단기 내에 무시할 수 있습니다. 이것이 여기서의 변수입니다. 월스트리트의 $330 목표는 재평가 촉매가 발생한다는 가정 하에 설정되었습니다. 현재의 차트는 그 어떤 촉매도 없다고 가정하고 있습니다. 다음 촉매를 누가 먼저 얻느냐에 따라 이번 주를 누가 이기느냐가 달라집니다.
4개 주요 AI 모델이 이 기사를 논의합니다
"Negative institutional and retail flows outweigh stale analyst targets and point to downside risk until volatility compresses or a catalyst appears."
The article correctly flags a clear divergence: every tracked firm rates NVDA a buy with targets up to $330, yet Chaikin Money Flow turned negative May 27 and retail volume May 15 while the stock consolidates below its $236.84 high. At 33.1% 30-day volatility, any sentiment shift can override the technical setup quickly. Missing context is that these upgrades largely react to April-May AI demand commentary rather than new data; if June or July order flows disappoint or macro risk-off accelerates, the $214 level could retest faster than targets adjust. The pole-and-flag pattern remains unconfirmed without volume confirmation.
The upgrades could front-run a re-acceleration in data-center bookings that the flow indicators have not yet captured, turning the current consolidation into a launch pad rather than a rollover.
"Institutional outflows after a 44% rally are profit-taking, not conviction loss; the real test is whether Q2 earnings confirm the AI TAM thesis or reveal demand destruction."
The article frames a classic disconnect: unanimous Wall Street bullishness ($288–$330 targets) versus deteriorating money flows and retail capitulation. But the framing is misleading. NVIDIA's 33.1% volatility and tight consolidation post-$236 peak suggest not weakness, but option positioning ahead of a catalyst—likely earnings or AI demand confirmation. Institutional outflows on May 27 could reflect profit-taking after a 44% rally, not conviction reversal. The article conflates technical weakness with fundamental rejection, ignoring that NVIDIA's forward multiples and TAM expansion justify re-rating. The real risk: if Q2 guidance disappoints, those $330 targets evaporate fast.
Wall Street's unanimous bullishness is itself a red flag—it suggests crowding and limited upside surprise. If the stock needed this many fresh buy ratings to hold $215, demand was already flagging before the article was written.
"The shift in institutional flow to negative territory, combined with elevated volatility, confirms that the current analyst upgrade cycle is being used as exit liquidity by major holders."
The disconnect between sell-side price targets and institutional money flow is a classic late-cycle divergence. While analysts are pricing in terminal growth for NVDA based on AI infrastructure spending, the Chaikin Money Flow breakdown suggests 'smart money' is aggressively distributing shares into the retail bid. At a 33% annualized volatility, NVDA is no longer a core holding; it is a speculative vehicle. If the stock fails to reclaim its 50-day moving average, the $330 targets become irrelevant as institutional exit liquidity dries up. We are seeing a 'sell the news' reaction to the analyst upgrade cycle, signaling that the immediate upside is fully priced in.
If hyperscalers like Microsoft or Meta announce a surprise increase in CAPEX for H100/Blackwell chip procurement, the current consolidation will be viewed as a mere pause before a massive vertical move.
"Negative money flow and fading retail participation, absent a concrete AI capex catalyst, imply a higher risk of a distribution-led pullback rather than a continued multiple expansion."
The article frames NVIDIA as a clear winner on sentiment (10 buy ratings, up to $330) while the chart tells a contrary story: a peak near $236 in May, then a pullback as institutional money turned negative (May 27) and retail volume faded (May 15). The stock’s elevated 30-day volatility (~33%) amplifies any catalystless moves, meaning sentiment-driven upside may fail without a material re-rating driver. Missing context includes whether AI capex cycles are accelerating or cooling, margin dynamics, and competition. If no tangible catalyst appears, the risk is a downside reversion toward prior support despite buoyant price targets.
The negative money flow could be a short-term liquidity wobble or noise; a solid earnings beat or clearer AI demand signal could snap the stock back toward the highs, making the downside risk overstated.
"Retail fade before institutional outflows signals pre-earnings distribution that price targets have yet to price in."
ChatGPT notes the May 15 retail fade but underplays how it preceded the May 27 CMF turn, pointing to coordinated distribution rather than isolated noise. With targets still anchored to April-May commentary and no new hyperscaler capex figures, any Q2 shortfall could compress multiples faster than volatility alone explains, pushing price toward $200 before analysts recalibrate.
"The May 15–27 sequence suggests coordinated distribution, but we need Q2 capex data to separate rational profit-taking from conviction reversal."
Grok's sequencing argument (retail fade May 15 → CMF turn May 27) is stronger than I credited, but it assumes causation from correlation. Institutional distribution into retail demand is plausible, yet the 44% rally Claude cited means profit-taking is equally rational. The real test: if Q2 bookings data arrives flat, do targets drop 15–20% or hold? That gap determines whether we're seeing smart exit or premature capitulation. Nobody's quantified the actual capex growth rate needed to justify $288+ targets.
"The analyst consensus ignores potential Blackwell production yield risks, which would invalidate current price targets even if demand remains high."
Claude, you’re missing the supply-side constraint: if institutional distribution is occurring, it isn't just profit-taking; it’s a hedge against the 'Blackwell' transition risk. If NVDA experiences a product cycle transition delay, those $330 targets are mathematically impossible to hit this year. We are ignoring that the analyst consensus assumes perfect execution on next-gen chip yields. If yields are even 5% below expectations, the margin compression will trigger a rapid multiple contraction regardless of hyperscaler demand.
"CMF weakness isn't proof of a top; the real risk is margin compression if yields underperform on capex slowdowns, which could drive multiple contraction despite TAM growth."
Gemini, I’d push back on the 'sell the news' read. A CMF drop and 50-day hesitation aren’t proof of a top; they can reflect option gamma hedging and hedge funds rebalancing into a structurally higher beta name. The risk you miss: if Blackwell/H100 yields disappoint, margin compression could hit even with TAM growth, forcing multiple contractions irrespective of catalysts. The debate isn’t just price level but whether risk/reward stays skewed to the downside on slower capex.
Despite unanimous buy ratings and high price targets, NVIDIA's recent technical indicators suggest weakness, with money flows turning negative and retail volume fading. The panel expresses concern about potential disappointments in Q2 bookings or AI demand, which could lead to multiple contractions and a retest of lower levels.
No tangible opportunity was explicitly stated by the panel.
Disappointing Q2 bookings data or a slowdown in AI capex growth could compress multiples and push the price toward $200, despite current price targets.